Scientists Testing Inhaler Protection Against the Coronavirus

September 16, 2020

As the world waits for the development of an immunization to give people immunity against COVID-19, scientists at University of California in San Francisco are looking to test an aerosol which they believe can protect users from the coronavirus.

Users could self-administer the aerosol, dubbed “AeroNabs,” through a nasal spray or inhaler. Used once a day, it could provide protection against SARS-CoV-2 until a vaccine becomes available. The research team is in active discussions with commercial partners to ramp up manufacturing and clinical testing of AeroNabs, which they describe as “molecular personal protective equipment (PPE).”

The coronavirus invades hosts through its spikes. These spikes can switch from a closed, inactive state to an open, active state, during which it can attach to human cells that line the lung and airway. The aerosol works by disabling the spikes, thereby preventing the virus from infecting hosts.

Latest Articles

Larry Levine
April 1, 2026 Jeff Cross

The Discipline Behind Consistent Results

April 1, 2026 Dr. Gavin Macgregor-Skinner

How Healthy Is Your Convention’s Venue?

March 31, 2026 Jeff Cross

Why Better Sales Training Won’t Fix Your Sales Problem

Sponsored Articles

Stop Clogs Before They Start With Bio Tech®
March 13, 2026

Stop Clogs Before They Start With Bio Tech®

March 13, 2026

Less is More™: Cleaning by Design Without the Waste

March 12, 2026 Sponsored by Lysol Pro Solutions

The Next Evolution of Air! Lysol Air Sanitizer for Modern Facilities

Recent News

Global Asbestos Awareness Week

Global Asbestos Awareness Week Promotes an End to Asbestos Exposure

Clorox Finalizes Acquisition of GOJO Industries, Makers of Purell®

US Companies Losing Thousands Per Manager Annually